Skip to main content
All lobbying filings

THE KROGER CO.

THE KROGER CO. filed a Q3 report for KROGER CO on October 20, 2025.

Lobbying for KROGER CO

All filings by THE KROGER CO. · Everything KROGER CO has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$290,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Ohio

Official filing document

 Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6
Food Industry (safety, labeling, etc.)

Issues related to the reauthorization of the Farm Bill; Issues related to the Supplemental Nutrition Assistance Program and WIC programs; Loan Agriculture Market Program; EBT process fees; issues related to the supply chain

Taxation/Internal Revenue Code

Issues related to corporate tax rates; Issues related to tariffs; Issues related to interchange reform

Health Issues

H.R. 1613, S. 1038 - Drug Price Transparency in Medicaid Act, including issues related to PBM Spread Pricing; S. 260, H.R. 704 - Promoting Access to Diabetic Shoes Act; H.R. 1770 - Equitable Community Access to Pharmacist Services Act; S. 127 - Pharmacy Benefit Manager Transparency Act; Issues related to Food as Medicine initiatives and pharmacy scope of practice; S. 1339 - Pharmacy Benefit Manager Reform Act; S. 2052 - Protect Patient Access to Pharmacies Act; H.R. 5378 - The Lower Costs, More Transparency Act; H.R. 2484 - Seniors Access to Critical Medications Act; S. 575 / H.R. 1317 - Improving Care and Access to Nurses Act

Consumer Issues/Safety/Products

Issues related to data privacy; H.R.1165 - Data Privacy Act of 2023; Implementation of California Consumer Privacy Act (CCPA) and the EU General Data Protection Regulation (GDPR); issues related to artificial intelligence; American Privacy Rights Act of 2024; Children & Teens' Online Privacy Protection Act (COPPA 2.0)

Financial Institutions/Investments/Securities

Issues related to card payments, including debit routing and interchange rates; Issues related to the Credit Card Competition Act

Law Enforcement/Crime/Criminal Justice

Issues related to organized retail crime; S.140, H.R.895 - Combating Organized Retail Crime Act of 2023

 Bills named in this filing 15
  • H.R. 1613
    Drug Price Transparency in Medicaid Act of 2023
  • S. 1038
    Drug Price Transparency in Medicaid Act of 2023
  • S. 260
    Promoting Access to Diabetic Shoes Act
  • H.R. 704
    Promoting Access to Diabetic Shoes Act
  • H.R. 1770
    Equitable Community Access to Pharmacist Services Act
  • S. 127
    Pharmacy Benefit Manager Transparency Act of 2023
  • S. 1339
    Pharmacy Benefit Manager Reform Act
  • S. 2052
    Protect Patient Access to Pharmacies Act
  • H.R. 5378
    Lower Costs, More Transparency Act
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
  • S. 575
    I CAN Act
  • H.R. 1317
    I CAN Act
  • H.R. 1165
    Data Privacy Act of 2023
  • S. 140
    Combating Organized Retail Crime Act of 2023
  • H.R. 895
    Combating Organized Retail Crime Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem